Aquarius Population Health

Evaluating the use AMR POCT in treatment of gonorrhoea

Point-of-care tests for STI

Aquarius Population Health recently worked with the Applied Diagnostic Research & Evaluation Unit (ADREU) at St. Georges, University of London, to assess the cost-effectiveness of six hypothetical strategies for using antimicrobial resistance point-of-care testing to guide the treatment of gonorrhoea.  Our findings were presented at the STI & HIV World Congress in Rio de Janeiro, Read More >

Evaluating multi-bug point-of-care tests for sexually transmitted infections

Evaluating multi-bug point-of-care tests for sexually transmitted infections

We were a collaborator on a recent Innovate UK-funded SBRI project with Binx and the Applied Diagnostic Research and Evaluation Unit at St George’s University of London. In this project, our team compared the overall costs, patient benefits and cost-effectiveness of three different multi-pathogen point-of-care testing strategies with the current strategy of microscopy and lab-based Read More >

Integrating Personalised Medicine into the NHS

Personalised Medicine

Personalised medicine is an emerging field that brings exciting changes to patient care. So, what exactly is personalised medicine and what are its benefits? In the past, various terms have been used interchangeably: ‘stratified medicine’, ‘personalised medicine’ and ‘precision medicine’. These terms refer to data driven medicine, in which data can be a patient’s genetic Read More >

Antimicrobial resistance point-of-care test for gonorrhoea

In a study commissioned by the Review on Antimicrobial Resistance, Aquarius Population Health worked with modellers at the University of Bristol to create a mathematical model. The model was used to assess the economic implications and treatment impact of introducing a hypothetical antimicrobial resistance (AMR) point-of-care test (POCT) for gonorrhoea. Results of the study were Read More >

Antimicrobial Resistance: Innovation in rapid diagnostics

Antimicrobial Resistance: Rapid Diagnostics

Part 3: What role does innovation such as rapid diagnostics have in preventing AMR? Just as new technology has helped us in the fight against global warming (fuel efficiency, clean energy etc.), technology can also help us in the fight against antimicrobial resistance (AMR). One such area is rapid diagnostics – identified as a key Read More >

Where are we with HIV in the UK?

Antimicrobial Resistance

HIV has profoundly impacted public health. Currently, 36.7 million people live with HIV worldwide and over 100,000 in the UK. According to data from Public Health England (PHE),  an estimated 6,000 people were newly diagnosed with HIV in the UK in 2015 and 13,500 people not yet diagnosed. Increasing awareness, swift diagnosis and provision of antiretroviral therapy Read More >

Improving patient care with rapid point of care tests

Dr Elisabeth Adams, Managing Director of Aquarius Population Health, presented on opportunities for rapid tests in influenza and HPV at international conferences in June. This has been a busy week for the Aquarius Population Health team. We had two posters at the Society for Medical Decision Making in London (12-15th June), which Elisabeth presented. The Read More >